| 1 |
Vertex Pharmaceuticals |
128.13 Bn |
120.28 Bn |
2.84 Bn |
1.59% |
| 2 |
Regeneron Pharmaceuticals |
112.33 Bn |
104.33 Bn |
3.93 Bn |
-76.72% |
| 3 |
Argenx Se |
53.24 Bn |
48.05 Bn |
1.41 Bn |
- |
| 4 |
Revolution Medicines |
43.64 Bn |
43.64 Bn |
- |
85.51% |
| 5 |
BeOne Medicines |
39.27 Bn |
34.17 Bn |
1.53 Bn |
12.13% |
| 6 |
MindWalk Holdings |
35.32 Bn |
35.31 Bn |
1.82 Bn |
90.10% |
| 7 |
Royalty Pharma |
33.72 Bn |
35.84 Bn |
- |
-48.36% |
| 8 |
Alnylam Pharmaceuticals |
30.58 Bn |
27.27 Bn |
992.69 Mn |
1,170.12% |
| 9 |
Insmed |
27.01 Bn |
25.85 Bn |
358.27 Mn |
99.48% |
| 10 |
BridgeBio Oncology Therapeutics |
726.38 Mn |
500.67 Mn |
- |
- |
